Status:
UNKNOWN
Opinions of Healthcare Providers About a European Neuromodulation Register
Lead Sponsor:
Moens Maarten
Collaborating Sponsors:
Vrije Universiteit Brussel
Conditions:
Registry
Neuromodulation
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this online survey is to gain further insights in the needs and burden for a European registry for neuromodulation, according to healthcare providers.
Eligibility Criteria
Inclusion
- Male and female adults who are involved in the management of chronic pain and more specifically in neuromodulation for pain (including but not limited to anesthesiologists, neurosurgeons, nurses).
Exclusion
- Not involved in management of chronic pain through neuromodulation.
Key Trial Info
Start Date :
August 31 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 2 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06030973
Start Date
August 31 2023
End Date
September 2 2023
Last Update
September 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Congres Center
Hamburg, Germany